Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSSE Regulatory News (SSE)

Share Price Information for SSE (SSE)

Share Price is delayed by 15 minutes
Get Live Data
2,358.00    -25.00 (-1.05%)
Bid:
2,363.00
Ask:
2,364.00
Spread: 1.00 (0.042%)
Market Cap: £28.44b
SSE Live PriceLast checked at - London Stock Exchange

Intraday SSE Share Chart

Non-Discretionary Share Buyback Programme

28 Sep 2022 07:00

RNS Number : 9149A
SSE PLC
28 September 2022
 

SSE Plc

Non-Discretionary Share Buyback Programme

SSE plc (the 'Company') confirmed on 30 August 2022 that it would initiate a £125m share buyback programme in line with its strategy to cap the scrip dividend option at 25% of investor take-up.  This share buyback programme is being undertaken solely in order to honour SSE's existing commitment to cap scrip dividend take-up at 25%. SSE is currently investing at record levels, ahead of profits, and has committed to reinvesting any additional profits derived from market variability directly back into energy infrastructure that will help tackle the underlying cause of the current energy crisis. In November 2021, SSE set out a lower, rebased dividend plan from 2023/24 as it prioritised growth and investment. Its current plans could see it invest £25bn in the UK and Ireland alone by the end of the decade, assuming a continued supportive policy environment.

In line with this, the Company announces that it has instructed both Credit Suisse International ('Credit Suisse') and Morgan Stanley & Co. International plc ('Morgan Stanley') in relation to an irrevocable non-discretionary programme to repurchase its ordinary shares for cancellation (the 'Programme'). The Programme will not exceed 6,904,083 ordinary shares, and the maximum pecuniary amount allocated to it is £125,000,000 (excluding expenses). The end date for the Programme will be the earlier of: when one of the aforementioned parameters are achieved; or 31 December 2022. The first half of the Programme will be executed by Credit Suisse and the second half will be executed by Morgan Stanley.

Any share purchases under the Programme will be effected within certain pre-set parameters, and in accordance with the Company's share buyback authority granted by shareholders at the Company's Annual General Meeting on 21 July 2022 (being up to 106,767,170 shares), the Market Abuse Regulation (596/2014) as it forms part of UK domestic law by virtue of the European Union (Withdrawal) Act 2018 as supplemented by the Market Abuse (Amendment) (EU Exit) Regulations SI2019/310 and the Commission Delegated Regulation (EU) 2016/1052 of 8 March 2016 supplementing Regulation (EU) No 596/2014 of the European Parliament and of the Council with regard to regulatory technical standards for the conditions applicable to buyback programmes and stabilisation measures including as it forms part of UK domestic law by virtue of the European Union (Withdrawal) Act 2018 (as amended by the Financial Conduct Authority's Technical Standards (Market Abuse Regulation) (EU Exit) Instrument 2019) and Chapter 12 of the UK Listing Rules. The Company confirms that it currently has no inside information.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
POSPPUMWBUPPPUM
Date   Source Headline
9th Jun 20264:34 pmRNSDirector/PDMR Shareholding
9th Jun 20263:47 pmRNSNotification of Admission to Trading
5th Jun 202612:39 pmRNSDirector/PDMR Shareholding
2nd Jun 20263:44 pmRNSIssue of Hybrid Capital Securities
1st Jun 202612:30 pmRNSAdmission to Trading
1st Jun 202612:21 pmRNSTotal Voting Rights
28th May 20267:00 amRNSPreliminary Results
7th May 20262:49 pmRNSDirector/PDMR Shareholding
1st May 20268:43 amRNSTotal Voting Rights
29th Apr 20264:38 pmRNSHolding(s) in Company
22nd Apr 20268:42 amRNSHolding(s) in Company
9th Apr 20264:45 pmRNSDirector/PDMR Shareholding
7th Apr 20262:27 pmRNSDirector/PDMR Shareholding
2nd Apr 20267:01 amEQSSSE PLC: Trading Update
1st Apr 20267:01 amEQSTotal Voting Rights
20th Mar 20262:57 pmRNSAdmission of Further Securities to Trading
9th Mar 20263:06 pmRNSDirector/PDMR Shareholding
9th Mar 20263:06 pmRNSDirector/PDMR Shareholding
2nd Mar 20267:00 amEQSTotal Voting Rights
2nd Mar 20267:00 amRNSSSENT accepts Ofgem’s RIIO-T3 Final Determination
24th Feb 20267:00 amRNSNotice of Redemption
12th Feb 20264:05 pmRNSDirector/PDMR Shareholding
11th Feb 20263:15 pmRNSHolding(s) in Company
10th Feb 20264:44 pmRNSDirector/PDMR Shareholding
4th Feb 202611:46 amRNSDirector/PDMR Shareholding
4th Feb 20267:00 amRNSQ3 Trading Statement
2nd Feb 20267:00 amEQSSSE PLC: Total Voting Rights
30th Jan 20262:52 pmRNSDirector/PDMR Shareholding
29th Jan 202612:00 pmRNSDirector/PDMR Shareholding
21st Jan 20264:15 pmRNSAdditional Admission Application
14th Jan 20267:25 amRNSSSE secures 1.4GW CfD for Berwick Bank Wind Farm
8th Jan 20263:28 pmRNSScrip Alternative
8th Jan 20262:54 pmRNSDirector/PDMR Shareholding
2nd Jan 20267:00 amRNSTotal Voting Rights
2nd Jan 20267:00 amRNSTotal Voting Rights
30th Dec 202510:33 amRNSDirector/PDMR Shareholding
30th Dec 202510:33 amRNSDirector/PDMR Shareholding
19th Dec 20257:00 amRNSSSEN Transmission-£1bn Facility backed by the NWF
19th Dec 20257:00 amRNSSSEN Transmission-£1bn Facility backed by the NWF
11th Dec 202511:40 amRNSScrip Dividend Scheme
10th Dec 20252:35 pmRNSHolding(s) in Company
10th Dec 20252:06 pmRNS2025 Sustainability Financing Framework
9th Dec 20253:50 pmRNSHolding(s) in Company
9th Dec 20253:48 pmRNSHolding(s) in Company
9th Dec 20251:52 pmRNSHolding(s) in Company
9th Dec 20251:41 pmRNSDirector/PDMR Shareholding
8th Dec 20251:14 pmRNSDirector/PDMR Shareholding
4th Dec 202511:44 amRNSHolding(s) in Company
4th Dec 20257:01 amRNSSSENT response to RIIO-T3 Final Determination
3rd Dec 202510:10 amRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.